RGS14 Regulation of Hormone-sensitive NPT2A-mediated Phosphate Transport

RGS14 激素敏感 NPT2A 介导的磷酸盐转运的调节

基本信息

  • 批准号:
    10317557
  • 负责人:
  • 金额:
    $ 46.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY: PTH and FGF23 initiate signaling pathways in renal proximal tubule cells that converge on the [NPT2A:NHERF1] complex to inhibit phosphate uptake. Mice lacking the PDZ protein NHERF1 and humans harboring NHERF1 mutations are hypophosphatemic. Important gaps exist in understanding the elements involved in these actions due to unidentified factors. Numerous GWAS studies of patients with chronic kidney disease implicate RGS14, which harbors a PDZ-recognition motif. We propose that RGS14 is a novel regulator of hormone-sensitive phosphate transport, and provide preliminary data to support this idea. RGS14 is scaffold that integrates G protein, MAPK, and Ca++/CaM signaling pathways. Its actions are best understood in rodent brain, where RGS14 suppresses synaptic plasticity and hippocampal-based learning. Nothing is known about RGS14 effects on hormone action or in kidney. Our preliminary findings show that RGS14 suppresses both PTH- and FGF23-regulated phosphate transport. RGS14 persistently attenuates PTH-regulated phosphate transport in primary human proximal tubule cells. RGS14 knock-down by siRNA reverses this action to reveal full PTH activity. RGS14 add-back to cells lacking the protein blocks PTH actions. Human RGS14 contains a C- terminal PDZ ligand (-DSAL) that directly binds NHERF1. Mutations in the PDZ-ligand disrupt RGS14 binding to NHERF1 and interfere with RGS14 regulation of hormone actions. These findings identify RGS14 as an entirely new element regulating hormone action on a vital homeostatic activity, and raise the hypothesis that RGS14 is a novel regulator of hormone-sensitive [NPT2A:NHERF1]-mediated phosphate transport in renal proximal tubule cells. Three Aims will test this premise. AIM 1 will define how RGS14 regulates assembly, disassembly of [NPT2A:NHERF1], its internalization and hormone-sensitive phosphate uptake. AIM 2 will define the locus of RGS14 effects on PTH and FGF23 signaling and the impact of hormone-directed NHERF1 phosphorylation on RGS14 regulation of the [NPT2A:NHERF1] complex. AIM 3: will define how PTH- and FGF23-directed signaling affect RGS14 interactions with NHERF1 and the [NHERF1:NPT2A] complex. These studies will identify novel roles and molecular mechanisms by which RGS14 regulates NPT2A function and hormone-sensitive phosphate transport in kidney as related to kidney disease.
项目总结:PTH和FGF23在肾近端小管细胞中启动信号通路

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter A Friedman其他文献

Peter A Friedman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter A Friedman', 18)}}的其他基金

RGS14 Regulation of Hormone-sensitive NPT2A-mediated Phosphate Transport
RGS14 激素敏感 NPT2A 介导的磷酸盐转运的调节
  • 批准号:
    10618970
  • 财政年份:
    2021
  • 资助金额:
    $ 46.54万
  • 项目类别:
RGS14 Regulation of Hormone-sensitive NPT2A-mediated Phosphate Transport
RGS14 激素敏感 NPT2A 介导的磷酸盐转运的调节
  • 批准号:
    10450178
  • 财政年份:
    2021
  • 资助金额:
    $ 46.54万
  • 项目类别:
Functional Polarity of PTH Receptor Signaling: Cellular and Molecular Mechanisms
PTH 受体信号传导的功能极性:细胞和分子机制
  • 批准号:
    9978053
  • 财政年份:
    2017
  • 资助金额:
    $ 46.54万
  • 项目类别:
Functional Polarity of PTH Receptor Signaling: Cellular and Molecular Mechanisms
PTH 受体信号传导的功能极性:细胞和分子机制
  • 批准号:
    9380356
  • 财政年份:
    2017
  • 资助金额:
    $ 46.54万
  • 项目类别:
BINDING CAPACITY OF THE PDZ2 DOMAIN OF NHERF1
NHERF1 的 PDZ2 结构域的结合能力
  • 批准号:
    8364320
  • 财政年份:
    2011
  • 资助金额:
    $ 46.54万
  • 项目类别:
COMPLEX FORMATION AND BINDING AFFINITY OF NHERF1 TO C-TERMINAL PEPTIDES
NHERF1 与 C 端肽的复合物形成和结合亲和力
  • 批准号:
    8364344
  • 财政年份:
    2011
  • 资助金额:
    $ 46.54万
  • 项目类别:
EBP50 REGULATION OF PTH RECEPTOR IN BONE AND KIDNEY
EBP50 对骨和肾中 PTH 受体的调节
  • 批准号:
    7903700
  • 财政年份:
    2009
  • 资助金额:
    $ 46.54万
  • 项目类别:
NOVEL REGULATORY MECHANISMS CONTROLLING BONE REPAIR AND OSTEOPOROSIS
控制骨修复和骨质疏松的新型调节机制
  • 批准号:
    7252994
  • 财政年份:
    2007
  • 资助金额:
    $ 46.54万
  • 项目类别:
NOVEL REGULATORY MECHANISMS CONTROLLING BONE REPAIR AND OSTEOPOROSIS
控制骨修复和骨质疏松的新型调节机制
  • 批准号:
    7447840
  • 财政年份:
    2007
  • 资助金额:
    $ 46.54万
  • 项目类别:
EBP50 REGULATION OF PTH RECEPTOR IN BONE AND KIDNEY
EBP50 对骨和肾中 PTH 受体的调节
  • 批准号:
    7049700
  • 财政年份:
    2006
  • 资助金额:
    $ 46.54万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 46.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 46.54万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 46.54万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 46.54万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 46.54万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 46.54万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 46.54万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 46.54万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 46.54万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 46.54万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了